CHURCH & DWIGHT CO INC /DE/ CHD
We were founded in 1846 and incorporated in Delaware in 1925. We develop, manufacture and market a broad range of consumer household and personal care products and specialty products focused on animal and food production, chemicals and cleaners. Our well-recognized brands include ARM & HAMMER® baking soda, cat litter, laundry detergent, carpet deodorizer and other baking soda-based products; OXICLEAN® stain removers, cleaning solutions, laundry detergents and bleach alternatives; BATISTE® dry shampoo; WATERPIK® water flossers; THERABREATH® oral care products; HERO® acne treatment products; TOUCHLAND® hand sanitizers; TROJAN® condoms, lubricants and vibrators; FIRST RESPONSE® home pregnancy and ovulation test kits; NAIR® depilatories; ORAJEL® oral analgesic; XTRA® laundry detergent; and ZICAM® cold shortening and relief products. Seven of those brands are designated as "power brands" because they compete in large categories, and we believe they have the potential for significant global expansion. Those seven brands are ARM & HAMMER®; OXICLEAN®; BATISTE®; WATERPIK®; THERABREATH®; HERO® and TOUCHLAND® and represent approximately 70% of our net sales and profits. Prior to the sale of our VITAFUSION® and L'IL CRITTERS® ("VMS") business at the end of 2025, we included VMS as an eighth "power brand."
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.20B | $6.11B | $5.87B | $5.38B | $5.19B | $4.90B | $4.36B | $4.15B | $3.78B | $3.49B |
| Cost of revenue | $3.43B | $3.32B | $3.28B | $3.13B | $2.93B | $2.68B | $2.37B | $2.31B | $2.05B | $1.90B |
| Gross profit | $2.77B | $2.79B | $2.59B | $2.25B | $2.26B | $2.21B | $1.98B | $1.84B | $1.73B | $1.59B |
| R&D | $145.6M | $139.7M | $122.4M | $110.0M | $105.2M | $102.6M | $93.6M | $89.7M | $70.8M | $63.2M |
| SG&A | $988.3M | $927.8M | $889.8M | $706.0M | $606.7M | $593.3M | $628.8M | $565.9M | $542.7M | $439.2M |
| Operating income | $1.08B | $807.1M | $1.06B | $597.8M | $1.08B | $1.03B | $840.2M | $791.7M | $732.7M | $724.2M |
| Interest expense | $95.2M | $95.0M | $110.9M | $89.6M | $54.5M | $61.0M | $73.6M | $79.4M | $52.6M | $27.7M |
| Pre-tax income | $956.9M | $756.3M | $967.4M | $523.3M | $1.03B | $973.8M | $773.7M | $719.5M | $692.7M | $705.9M |
| Income tax | $220.1M | $171.0M | $211.8M | $109.4M | $204.2M | $187.9M | $157.8M | $150.9M | $50.7M | $246.9M |
| Net income | $736.8M | $585.3M | $755.6M | $413.9M | $827.5M | $785.9M | $615.9M | $568.6M | $743.4M | $459.0M |
| EPS, basic | 3.04 | 2.39 | 3.09 | 1.70 | 3.38 | 3.18 | 2.50 | 2.32 | 2.97 | 1.78 |
| EPS, diluted | 3.02 | 2.37 | 3.05 | 1.68 | 3.32 | 3.12 | 2.44 | 2.27 | 2.90 | 1.75 |
| Shares, diluted (wtd. avg.) | $244.3M | $246.9M | $247.6M | $246.3M | $249.6M | $252.2M | $252.1M | $250.7M | $256.1M | $262.1M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $409.0M | $964.1M | $344.5M | $270.3M | $240.6M | $183.1M | $155.7M | $316.7M | $278.9M | $187.8M |
| Receivables | $593.4M | $600.8M | $526.9M | $422.0M | $405.5M | $398.8M | $356.4M | $345.3M | $345.9M | $287.0M |
| Inventory | $534.8M | $613.3M | $613.3M | $646.6M | $535.4M | $495.4M | $417.4M | $382.8M | $330.7M | $258.2M |
| Total current assets | $1.60B | $2.24B | $1.53B | $1.40B | $1.23B | $1.11B | $956.4M | $1.08B | $1.00B | $756.8M |
| Property, plant and equipment | $822.8M | $931.7M | $927.7M | $761.1M | $652.7M | $612.8M | $598.2M | $563.0M | $607.7M | $588.6M |
| Goodwill | $2.63B | $2.43B | $2.43B | $2.43B | $2.27B | $2.23B | $2.08B | $1.99B | $1.96B | $1.44B |
| Other intangibles | $3.51B | $2.89B | $3.30B | $3.43B | $3.49B | $3.11B | $2.75B | $2.27B | $2.32B | $1.43B |
| Total assets | $8.91B | $8.88B | $8.57B | $8.35B | $8.00B | $7.41B | $6.66B | $6.07B | $6.01B | $4.35B |
| Accounts payable | $732.4M | $705.1M | $630.6M | $666.7M | $1.12B | $1.02B | $725.1M | $738.7M | $659.1M | $568.9M |
| Short-term debt | — | $0 | $199.9M | $0 | $699.4M | $0 | $252.9M | $596.5M | $0 | $426.8M |
| Total current liabilities | $1.50B | $1.32B | $1.42B | $1.18B | $2.08B | $1.39B | $1.09B | $1.33B | $935.0M | $1.00B |
| Long-term debt | $2.21B | $2.20B | $2.20B | $2.60B | $2.20B | $1.81B | $1.81B | $1.51B | $2.10B | $693.4M |
| Total liabilities | $4.91B | $4.52B | $4.71B | $4.86B | $4.76B | $4.39B | $3.99B | $3.62B | $3.80B | $2.38B |
| Retained earnings | $6.77B | $6.32B | $6.01B | $5.52B | $5.37B | $4.79B | $3.83B | $3.85B | $3.48B | $2.93B |
| Total equity | $4.00B | $4.36B | $3.86B | $3.49B | $3.23B | $3.02B | $2.67B | $2.45B | $2.22B | $1.98B |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.22B | $1.16B | $1.03B | $885.2M | $993.8M | $990.3M | $864.5M | $763.6M | $681.5M | $655.3M |
| Depreciation and amortisation | $247.4M | $239.1M | $225.2M | $219.0M | $219.1M | $189.7M | $176.4M | $141.1M | $125.4M | $107.6M |
| Stock-based compensation | $58.0M | $59.2M | $63.6M | $32.3M | $23.7M | $21.5M | $20.8M | $23.3M | $18.1M | $16.0M |
| Capital expenditure | $122.4M | $179.8M | $223.5M | $178.8M | $118.8M | $98.9M | $73.7M | $60.4M | $45.0M | $49.8M |
| Investing cash flow | -$616.9M | -$183.3M | -$234.3M | -$728.6M | -$682.0M | -$608.1M | -$553.5M | -$112.1M | -$1.30B | -$354.6M |
| Financing cash flow | -$1.16B | -$343.4M | -$725.6M | -$120.9M | -$252.1M | -$360.1M | -$472.9M | -$609.0M | $698.9M | -$439.6M |
| Dividends paid | $287.2M | $277.0M | $266.5M | $255.0M | $247.5M | $237.3M | $224.1M | $213.3M | $190.4M | $183.0M |
| Buybacks | $900.0M | $0 | $300.1M | $0 | $500.0M | $300.0M | $250.0M | $200.0M | $400.0M | $400.0M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-048139.
Others in SIC 2840
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| PG | PROCTER & GAMBLE Co | $340.39B | 22.1x | 3.3% |
| ECL | ECOLAB INC. | $78.29B | 38.4x | 2.2% |
| SCL | STEPAN CO | $1.44B | 30.9x | 7.0% |
| UL | UNILEVER PLC | — | — | — |
| WNW | Meiwu Technology Co Ltd | — | — | 4,368.0% |
| BYAH | Park Ha Biological Technology Co., Ltd. | — | — | 6.0% |